Finance

Lists
SVA:NASDAQ
Sinovac Biotech Ltd
$6.47
0.00%
(0.00) 1D
Feb 22, 5:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SVA...
Volume
0.00
52-wk high
$28.18
52-wk low
$22.40
EPS
-$1.37
Shares outstanding
59.32M
No. of employees
3K
Volume
0.00
52-wk high
$28.18
52-wk low
$22.40
EPS
-$1.37
Shares outstanding
59.32M
No. of employees
3K
Profile
Sinovac Biotech Ltd. is a Chinese biopharmaceutical company based in Haidian District, Beijing, that focuses on the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company was listed on the Nasdaq but the exchange halted Sinovac's trading in February 2019 due to a proxy fight. The company has faced bribery probes in China. Its COVID-19 vaccine was the target of a covert disinformation campaign by the US government and a promotional social media astroturfing campaign by the Chinese government. Wikipedia
About Sinovac Biotech Ltd
CEOWeidong Yin
Employees2.6K
Founded2001
Headquarters-
SectorBiotechnology
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
127.87M
127.87M
73.54M
73.54M
Cost of goods sold
37.61M
37.61M
25.77M
25.77M
Cost of revenue
37.61M
37.61M
25.77M
25.77M
Research and development expenses
44.63M
44.63M
41.58M
41.58M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
92.88M
92.88M
65.46M
65.46M
Operating expense
139.74M
139.74M
106.75M
106.75M
Total operating expenses
177.35M
177.35M
132.52M
132.52M
Operating income
-49.48M
-49.48M
-58.98M
-58.98M
Other non operating income
-130.35M
-130.35M
10.55M
10.55M
EBT including unusual items
-83.16M
-83.16M
-34.92M
-34.92M
EBT excluding unusual items
-16.72M
-16.72M
-34.88M
-34.88M
Income tax expense
-32.02M
-32.02M
10.78M
10.78M
Effective tax rate
38.51%
38.51%
-30.87%
-30.87%
Other operating expenses
-245.50K
-245.50K
-33.00K
-33.00K
Net income
-19.01M
-19.01M
-30.12M
-30.12M
Net profit margin
-14.86%
-14.86%
-40.96%
-40.96%
Earnings per share
-
-
-
-
Interest and investment income
163.87M
163.87M
9.05M
9.05M
Interest expense
-2.86M
-2.86M
-2.39M
-2.39M
Net interest expenses
161.01M
161.01M
6.67M
6.67M
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.04M
-25.04M
-36.38M
-36.38M
Gain or loss from assets sale
41.66M
41.66M
42.50K
42.50K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google apps